Large Language Model Assistance for Clinical Decision-Making Among Rural Physicians

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorPeking University Third Hospital

About this trial

This study will evaluate whether, relative to conventional information retrieval approaches, direct large language models (LLM) access and LLM use training can improve the overall clinical decision-making ability of rural physicians in low-resource grassroots healthcare settings.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Currently engaged in clinical practice at a rural primary healthcare institution in northwestern China.

Has received formal medical education and holds a relevant diploma or degree.

Able to read and understand clinical case materials in Chinese.

Able to use a computer to complete the study tasks.

Disqualifiers

Previously involved in the development of the clinical case tasks, reference answers, or scoring rubric for this study.

Previously participated in pilot testing involving the same clinical case tasks or study procedures.

Trial design

Design model

Factorial

Treatments tested in this trial

  • LLM-Use Training

    Behavioral

    Before completing the clinical cases, participants receive brief structured training on the safe and effective use of LLMs. The training covers the role and limitations of LLMs, structured prompting and follow-up questioning, identification of warning signs and referral indications, medication safety, verification of LLM-generated information, high-risk situations in which LLMs should not be relied upon, and protection of patient privacy.

  • Conventional Non-LLM Resources

    Other intervention

    During the initial 60-minute assessment, participants complete primary care clinical cases using conventional non-LLM resources only, including clinical guidelines, textbooks, drug labels, training materials, medical websites, and standard search engines. Participants are not permitted to use LLMs during this phase.

  • LLM Second-Opinion Review

    Other intervention

    After completing and submitting their initial responses using conventional non-LLM resources, participants receive an additional 30 minutes to use the study-provided DeepSeek-V4 as a second-opinion tool. They may review, verify, and revise their initial clinical decisions before submitting their final responses.

  • Direct LLM Assistance

    Other intervention

    During the initial 60-minute assessment, participants may use the study-provided DeepSeek-V4 to assist with medical information retrieval, diagnostic and management reasoning, identification of warning signs, referral decisions, rational prescribing, patient education, and follow-up planning. Participants remain responsible for their final clinical decisions and responses.

Treatment groups

240 Participants
are divided into 4 treatment groups
Group A: Conventional Resources Followed by LLM Second OpinionActive comparator 2 interventions
Group B: Direct LLM AssistanceExperimental treatment 1 intervention
Group C: LLM Training and Conventional Resources Followed by LLM Second OpinionExperimental treatment 3 interventions
Group D: LLM Training and Direct LLM AssistanceExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Overall Clinical Decision-Making Score

Participants' responses to primary care clinical cases will be evaluated using a prespecified scoring rubric. The overall score will reflect performance across key components of clinical decision-making. Higher scores indicate better overall clinical decision-making performance.

Time frame
At the end of the initial 60-minute assessment

Secondary outcomes

1

Diagnostic Judgment Domain Score

Participants' diagnostic judgment in response to primary care clinical cases will be evaluated using a predefined scoring rubric. Higher scores indicate better diagnostic judgment.

Time frame
At the end of the initial 60-minute assessment
2

Clinical Warning Sign Recognition Domain Score

Participants' ability to identify clinically important warning signs in primary care clinical cases will be evaluated using a predefined scoring rubric. Higher scores indicate better recognition of clinical warning signs.

Time frame
At the end of the initial 60-minute assessment
3

Treatment Plan Domain Score

Participants' proposed treatment plans for primary care clinical cases will be evaluated using a predefined scoring rubric. Higher scores indicate better treatment planning performance.

Time frame
At the end of the initial 60-minute assessment
4

Change in Overall Clinical Decision-Making Score After LLM Review

Among participants assigned to the LLM second-opinion phase, the change in overall clinical decision-making score will be calculated as the score after LLM-assisted review minus the score before LLM-assisted review. Positive values indicate improvement in overall clinical decision-making performance.

Time frame
Change from 60 to 90 minutes after the start of the assessment

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Peking University Third Hospital

Lead sponsor

Xinjiang Second Medical College

Collaborator

This trial is not recruiting at the moment. You can still explore other options: